2021 | Jiménez L., Silva A., Calissi G., Grenho I., Monteiro R., Blanco-Aparicio C., Mayoral-Varo V., Pastor J., Bustos V., Bracher F., Megias D., Ferreira B.I.* and Link W.*. Screening health-promoting compounds for their capacity to induce the activity of FOXO3. Journal of Gerontology doi: 10.1093/gerona/glab265. PMID: 34508571
2021 | Ferreira B.I., Santos B., Link W. and De Sousa-Coelho AL. Tribbles Pseudokinases in Colorectal Cancer. Cancers (Basel) 13, 2825. doi: 10.3390/cancers13112825, PMID: 34070799
2021 | Hazael Pérez-Beltrána C., García-Guzmán J.J., Ferreira B., Estévez-Hernández O., López-Iglesias D., Cubillana-Aguilera L., Link W., Stănicăhe N., dos Santos Rosa da Costa A.M. and Palacios-Santander J.M.. One-minute and green synthesis of magnetic iron oxide nanoparticles assisted by design of experiments and high energy ultrasound: Application to biosensing and immunoprecipitation. Mater Sci Eng C Mater Biol Appl. 123, 112023. doi: 10.1016/j.msec.2021.112023. PMID: 33812640
2020 | Machado S., Silva A., De Sousa-Coelho A.L., Duarte I., Grenho I., Santos B., Mayoral-Varo V., Megias D., Sánchez-Cabo F., Dopazo A., Ferreira B.I. and Link W.. Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance. Cancers (Basel) 9, 12 doi: 10.3390/cancers12123689, PMID: 33316942
2020 | Ferreira B.I., Cautain B., Grenho I. and Link W. . Small molecule inhibitors of CRM1. Frontiers in Pharmacology 11, 625. doi: 10.3389/fphar.2020.00625, PMID: 32574233
2020 | Jacinto F.V., Link W., Ferreira B.I.. CRISPR/Cas9-mediated genome editing: from basic research to translational medicine. Journal of Cellular and Molecular Medicine 24, 3766-3778. doi: 10.1111/jcmm.14916.
2019 | Machado S., Raposo C., Ferreira B.I. and Link W.. Image-based identification of chemical compounds capable of trapping FOXO in the cell nucleus. Methods Mol Biol. 1890, 163-170. doi: 10.1007/978-1-4939-8900-3_14, PMID: 30414153
2019 | Henriques V, Machado S., Link W. and Ferreira B.I.. Monitoring the transcriptional activity of FOXO transcription factors by analyzing their target genes. Methods Mol Biol. 1890:103-113. doi: 10.1007/978-1-4939-8900-3_9, PMID: 30414148
2018 | Link W.. Knowledge-based drug discovery intensifies private appropriation of publicly financed research. The Lancet Oncology 19, 1017-1018. doi: 10.1016/S1470-2045(18)30437-6, PMID: 30102212
2018 | Henriques V., Martins M., Link W. and Ferreira B.I. The emerging therapeutic landscape of advanced melanoma, Current Pharmaceutical Design, 24, 549-558. doi: 10.2174/138161282466618012509335, PMID: 29366407
2017 | Link W. and Fernandez-Marcos P.. FOXO transcription factors at the interface of metabolism and cancer. International Journal of Cancer 141, 2379-2391. doi: 10.1002/ijc.30840. PMID: 28631330 Cover image and story
2017 | Link W.. Mind the gap, see the immuno-connection. Nature Chem. Biol. 13, 572-573.doi: 10.1038/nchembio.2373. PMID: 28437396
2017 | Hill R., Madureira PA, Ferreira, B, Baptista. I, Machado, S, Colaço L., dos Santos M., Liu N., Dopazo, A, Ugurel S., Adrienn A., Kiss-Toth E., Isbilen M., Gure AO and Link W.. TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT. Nature Comm. 8, 14687. doi: 10.1038/ncomms14687. PMID: 28276427
2017 | Ferreira BI, Lie MK, Engelsen AST, Machado S, Link W and James B. Lorens. Adaptive mechanisms of resistance to antineoplastic agents. MedChemComm, 8, 53 – 66. DOI: 10.1039/C6MD00394J, PMID: 30108690
2016 | Cautien B., Castillo F, Musso L, de Pedro N, Rodriguez Quesada L, Vicente Pérez F, Dallavalle S and Link W.. Discovery of a novel, specific isothiazolonaphthoquinone-based small molecule activator of FOXO nuclear-cytoplasmic shuttling. PLoS One 11(12):e0167491. doi: 10.1371/journal.pone.0167491, PMID: 27936162
2016 | Florindo, C, Ferreira BI, Serrão SM, Tavares, AA, Hill R, and Link W.. Subcellular protein localization in health and disease. eLS. John Wiley & Sons, Ltd: Chichester DOI: 10.1002/9780470015902.a0026534
2016 | Martins R., Lithgow G.J., Link W.. Long live FOXO: Unravelling the role of FOXO proteins in aging and longevity. Aging Cell 15, 196-207. doi: 10.1111/acel.12427, PMID: 26643314
2013 | Rio-Machin A, Ferreira BI, et al. and Cigudosa JC. “Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype”, Leukemia
2008 | Marcos NT, Magalhães A, Ferreira B, et al., Reis CA. “Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x”, Journal of Clinical Investigation
2008 | Ferreira BI, et al. and Cigudosa JC “Comparative genome profiling across sub-types of low grade B cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia”. Haematologica
2008 | Ferreira BI, et al. and Cigudosa JC. “Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing’s sarcoma.” Oncogene
